Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Patrick O'Neil | M | 50 | 23 ans | |
| Elizabeth Hougen | F | 62 | 24 ans | |
| Spencer Berthelsen | M | 71 | 22 ans | |
| Sanjay Bhanot | M | - | 24 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Frederick Muto | M | 70 | 21 ans | |
| Dan Kisner | M | 77 | 8 ans | |
| John Reed | M | 65 | 11 ans | |
| Richard K. Brown | M | 71 | - | |
| Susan Knudson | F | 60 | - | |
| Daniel Ripley | M | 63 | 6 ans | |
| Ethel M. Koczon | F | - | 5 ans | |
| Pratik Multani | M | 57 |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | 1 ans |
| Jon T. Holmlund | M | 67 | 7 ans | |
| Muthiah Manoharan | M | - | 13 ans | |
| Gary J. G. Atkinson | M | 71 | 5 ans | |
| Ronald C. Griffith | M | 76 | - | |
| Aaron Davidson | M | 55 |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | 2 ans |
| Edgardo Baracchini | M | 64 | 4 ans | |
| John A. McNeil | M | 59 | - | |
| Lisa R. Grillone | M | 74 | 10 ans | |
| Sam Wertheimer | M | 63 |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | 1 ans |
| William R. Shanahan | M | 74 | 6 ans | |
| Karin Eastham | F | 74 |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | - |
| Mark K. Wedel | M | 77 | 7 ans | |
| David Slack | M | 61 | 4 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 25 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- F. Andrew Dorr
- Réseau Personnel
